NTRA Lobbyist: Federal Drug Reform Action Unlikely

Advocates for change in horse racing didn’t find much reason for optimism in the National Thoroughbred Racing Association’s legislative update held in Saratoga Springs Aug. 7.

The presentation from lobbyist Greg Means, founder and principal of The Alpine Group in Washington, D.C., reviewed current legislation or proposals that pertain to racing. Included were bills covering the ways gamblers’ winnings are reported and taxed, the acceleration of depreciation of Thoroughbreds for tax purposes, which expired at the end of 2013, and medication reform.

Means assessed the viability of federal intervention into the regulation of medication in racing, specifically a bill that would install the United States Anti-Doping Association as the regulator to develop guidelines and rules regarding medication use.

“What I think is going to happen to this bill,” he said, “is nothing.”

Read more on BloodHorse.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s